Biopharma

Bayer’s turnaround man faces ‘crucial’ year at ailing conglomerate

Bayer’s turnaround man faces ‘crucial’ year at ailing c...

Mar 3, 2025 0

Bill Anderson ‘stands and falls’ with direction of European group’s flagging sha...

STAT+: Marty Makary, Trump nominee to lead FDA, pledges to avoid conflicts if confirmed

STAT+: Marty Makary, Trump nominee to lead FDA, pledges...

Mar 3, 2025 0

Marty Makary, President Trump’s pick to be FDA commissioner, promised to step do...

Takeda rains 100 toy zebras down on Boston Celtics fans to mark Rare Disease Day

Takeda rains 100 toy zebras down on Boston Celtics fans...

Mar 3, 2025 0

Takeda made it rain zebras at a Boston Celtics game Friday. The stunt saw 100 to...

STAT+: DOJ probes device maker whose test resulted in lucrative diagnoses for UnitedHealth and other insurers

STAT+: DOJ probes device maker whose test resulted in l...

Mar 3, 2025 0

The Department of Justice is investigating Semler Scientific for possible violat...

Roche touts head-to-head data for Xolair against oral immunotherapy for treating food allergies

Roche touts head-to-head data for Xolair against oral i...

Mar 3, 2025 0

A year after the FDA blessed Roche and Novartis’ Xolair (omalizumab) as the firs...

STAT+: Sutter Health settles sweeping antitrust case, narrowly avoiding trial

STAT+: Sutter Health settles sweeping antitrust case, n...

Mar 3, 2025 0

Plaintiffs accused Sutter Health, a nonprofit, of illegally wielding its market ...

Bristol Myers' cost-savings drive claims another 223 jobs in NJ

Bristol Myers' cost-savings drive claims another 223 jo...

Mar 3, 2025 0

Beginning in late May, BMS will lay off 223 workers in Lawrenceville, New Jersey...

Sotagliflozin Cuts MACE Rate in Patients With T2DM, CKD, CVD Risk Factors

Sotagliflozin Cuts MACE Rate in Patients With T2DM, CKD...

Mar 3, 2025 0

MONDAY, March 3, 2025 -- For patients with type 2 diabetes, chronic kidney dise...

Psychosomatic Misdiagnosis Can Have Lasting Negative Impact on Patients

Psychosomatic Misdiagnosis Can Have Lasting Negative Im...

Mar 3, 2025 0

MONDAY, March. 3, 2025 -- Chronic diseases misdiagnosed as psychosomatic can le...

Ultra-Rapid Molecular-Genetic Assays Feasible for Tumor Classification During Surgery

Ultra-Rapid Molecular-Genetic Assays Feasible for Tumor...

Mar 3, 2025 0

MONDAY, March 3, 2025 -- Intraoperative ultra-rapid droplet digital polymerase ...

AAN: Prophylactic Zonisamide Effective in Pediatric Migraine

AAN: Prophylactic Zonisamide Effective in Pediatric Mig...

Mar 3, 2025 0

MONDAY, March 3, 2025 -- For pediatric patients with migraine, prophylactic zon...

GLP-1 Receptor Agonist Use Not Linked to Increased Suicide Risk

GLP-1 Receptor Agonist Use Not Linked to Increased Suic...

Mar 3, 2025 0

MONDAY, March 3, 2025 -- Glucagon-like peptide-1 (GLP-1) receptor agonists are ...

AAN: Marine Microplastic Levels Linked to Cognitive, Other Disabilities

AAN: Marine Microplastic Levels Linked to Cognitive, Ot...

Mar 3, 2025 0

MONDAY, March 3, 2025 -- Marine microplastic levels (MMLs) are associated with ...

Mortality Increased With Hospital-Based Care for Hallucinogen Use

Mortality Increased With Hospital-Based Care for Halluc...

Mar 3, 2025 0

MONDAY, March 3, 2025 -- Hospital-based care for hallucinogen use is associated...

Paragonix’s donor kidney perfusion system completes commercial flight

Paragonix’s donor kidney perfusion system completes com...

Mar 3, 2025 0

The KidneyVault is more than a simple ice chest. It pumps a cooled, specialized ...

STAT+: How DOGE is hitting CMS, and another go with transparency

STAT+: How DOGE is hitting CMS, and another go with tra...

Mar 3, 2025 0

In this week's Health Care Inc. newsletter: How DOGE is hitting CMS, another go ...

Biotech startup pulls in $187M to make ‘multi-payload’ ADCs

Biotech startup pulls in $187M to make ‘multi-payload’ ...

Mar 3, 2025 0

Callio Therapeutics is launching with an ADC technology and programs licensed fr...

STAT+: Sutter Health settles with government in sweeping antitrust case

STAT+: Sutter Health settles with government in sweepin...

Mar 3, 2025 0

Plaintiffs accused Sutter Health, a nonprofit, of illegally wielding its market ...

Sinusitis data from Amgen, AZ's Tezspire spark 'best-in-disease' talk amid Sanofi, GSK competition

Sinusitis data from Amgen, AZ's Tezspire spark 'best-in...

Mar 3, 2025 0

Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has ...

PSUSA/00002943/202406

PSUSA/00002943/202406

Mar 3, 2025 0

PSUSA/00002943/202406

AbbVie gets into obesity with $350M deal for once-weekly shot

AbbVie gets into obesity with $350M deal for once-weekl...

Mar 3, 2025 0

A licensing deal with Denmark’s Gubra gives the immunology giant control of an e...

Pliant discontinues late-stage lung disease trial for lead asset after safety review

Pliant discontinues late-stage lung disease trial for l...

Mar 3, 2025 0

Pliant Therapeutics has discontinued a phase 2b/3 trial after recording at least...

STAT+: RFK Jr. moves to eliminate public comment on HHS decisions

STAT+: RFK Jr. moves to eliminate public comment on HHS...

Mar 3, 2025 0

HHS Secretary Robert F. Kennedy Jr. moved to rescind the longtime practice of gi...

Human medicines European public assessment report (EPAR): Ultibro Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 19/09/2013, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Ultibro Breezhaler, in...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.